Dexamethasone in neonatal chronic lung disease: pulmonary effects and intracranial complications
โ Scribed by C. M. Noble-Jamieson; R. Regev; M. Silverman
- Publisher
- Springer
- Year
- 1989
- Tongue
- English
- Weight
- 235 KB
- Volume
- 148
- Category
- Article
- ISSN
- 0340-6997
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
This study assessed whether respiratory rates (RRs) correlate with urinary growth hormone (U-GH) excretion and sleep architecture in infants with chronic neonatal lung disease (CNLD) in early (1 month), middle (6 months), and late (10 months) infancy. Twenty-three preterm infants (CNLD = 16, control
Sleep fragmentation, decreased rapid eye movement (REM) sleep time, and REM sleep hypoxemia have been reported in infants with chronic neonatal lung disease (CNLD) in early infancy despite an awake hemoglobin oxygen saturation (SaO 2 ) >93%. Interestingly, higher inspired O 2 concentrations have bee
The purpose of this study was to compare the effects of daily inhaled beclomethasone (3 ร 500 ยตg) started on day 3 of life, with that of systemic dexamethasone (0.5 mg/kg/day) started between days 11-13 on clinical variables, lung inflammation, and pulmonary microvascular permeability in preterm inf